跳至主要内容
临床试验/NCT02578355
NCT02578355尚未招募不适用

National Plaque Registry and Database

Semmelweis University Heart and Vascular Center11 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20,000
试验地点
11
主要终点
All cause death

研究概览

简要总结

The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction.

Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death.

The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.

详细描述

The primary goals of OPeRA consortium:

To develop a national coronary CTA registry with the collaboration of all major cardiac CT centers of Hungary (Országos Plaque Regiszter és Adatbázis - NatiOnal Plaque Registry and DAtabase, OPeRA).

  1. To develop a novel risk assessment tool (OPeRA score) based on image markers and clinical characteristics.
  2. To identify and validate novel vulnerable coronary plaque image markers and assess their prognostic value.

Secondary goals:

  1. To develop a standardized and structured, national coronary CTA reporting system.
  2. To establish a national quality control system that monitors the quantity of iodinated contrast agent and the patients' radiation dose.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Subject providing written informed consent
  • Scheduled to undergo a clinically indicated coronary CTA

排除标准

  • Age <18 years
  • Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
  • Recent prior myocardial infarction within 30 days prior to coronary CTA or between coronary CTA and ICA
  • Pregnancy or unknown pregnancy status in subject of childbearing potential
  • Subject requires an emergent procedure
  • Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema
  • Inability to comply with study procedures

结局指标

主要结局

All cause death

时间窗: 10 years

次要结局

  • CAD-related hospitalization(10 years)
  • Unstable angina(10 years)
  • Myocardial infarction(10 years)
  • Target vessel revascularization(10 years)

研究者

发起方
Semmelweis University Heart and Vascular Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pál Maurovich-Horvat

Assistant Professor

Semmelweis University Heart and Vascular Center

研究点 (11)

Loading locations...

相似试验